-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Probenecid-d14
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1189657-87-12d.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 1189657-87-1 |
| Description | Probenecid-[d14] is the labelled analogue of Probenecid. Probenecid is a drug that increases the excretion of uric acid in the urine and can be used to treat gout and hyperuricemia. |
Product Information
| Synonyms | Probenecid-d14;1189657-87-1;4-[bis(1,1,2,2,3,3,3-heptadeuteriopropyl)sulfamoyl]benzoic acid;Probenecid-d14 (di-n-propyl-d14);4[(Dipropylamino-d14)sulfonyl]benzoic Acid;HY-B0545S;DA-77072;CS-0201015;F91263; |
| IUPAC Name | 4-[bis(1,1,2,2,3,3,3-heptadeuteriopropyl)sulfamoyl]benzoic acid |
| Molecular Weight | 299.45 |
| Molecular Formula | C13H5D14NO4S |
| Canonical SMILES | S(N(C(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H])C(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H])(=O)(=O)C1=CC=C(C(O)=O)C=C1 |
| InChI | InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)/i1D3,2D3,3D2,4D2,9D2,10D2 |
| InChIKey | DBABZHXKTCFAPX-YTSTUSJFSA-N |
| Melting Point | 193-195°C |
| Purity | >95% |
| Solubility | Soluble in Chloroform (Slightly), Methanol (Slightly) |
| Appearance | White Solid |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
